国际中医中药杂志
國際中醫中藥雜誌
국제중의중약잡지
INTERNATIONAL JOURNAL OF TRIDITIONAL CHINESE MEDICINE
2015年
5期
396-400
,共5页
张路%林佩君%李蕾%王克键%许智先%郭梦萌%沈建武%徐峰
張路%林珮君%李蕾%王剋鍵%許智先%郭夢萌%瀋建武%徐峰
장로%림패군%리뢰%왕극건%허지선%곽몽맹%침건무%서봉
鼻炎,变应性,常年性%针刺%神经节,副交感%生活质量
鼻炎,變應性,常年性%針刺%神經節,副交感%生活質量
비염,변응성,상년성%침자%신경절,부교감%생활질량
Rhinitis,allergic,perennial%Acupuncture%Ganglia,parasympathetic%Quality of life
目的：评价针刺蝶腭神经节治疗中重度持续性变应性鼻炎的临床疗效。方法本研究为非随机对照研究。将符合纳入标准的患者按就诊顺序以1∶1比例分为2组，每组25例。针刺蝶腭神经节组采用毫针刺激蝶腭神经节，1～2次/周；常规针刺组采用传统针刺方法，以迎香、印堂、风池、风府、足三里等为主穴，以上星、合谷、禾髎、肺俞、脾俞、肾俞、三阴交等为配穴，每次取主穴、配穴各1～2穴，2次/周。2组均连续治疗4周。采用鼻炎症状总分量表(2004版)、鼻炎症状总分量表(total nasal symptom score, TNSS)、鼻炎伴随症状总分量表(total non-nasal symptom score, TNNSS)评价症状改善情况；采用鼻结膜炎生活质量量表(rhinoconjunctivitis quality of life questionnaire, RQLQ)评价生活质量；比较2组患者针刺起效时间、疗效持续时间，以及治疗后1个月复发天数。结果针刺蝶腭神经节组治疗后鼻炎症状总分[(99.74±31.89)分比(196.83±31.22)，t＝-4.912]、TNSS[(165.18±51.06)分比(209.37±53.31)分，t＝-4.032]、TNNSS[(33.63±12.37)分比(71.82±19.21)，t＝-3.463]均明显低于常规针刺组(P 均＜0.05)。与常规针刺组比较，针刺蝶腭神经节组针刺后症状改善起效时间[(13.85±4.21)min 比(45.63±7.87)min；t＝-1.763,P＝0.008]更短，而疗效持续时间[(37.92±9.94)h 比(3.35±1.23)h；t＝7.637,P＜0.01]更长。针刺蝶腭神经节组治疗后4周RQLQ评分[(8.48±3.71)分比(37.68±12.46)分，F＝-7.312]低于常规针刺组(P＜0.01)。治疗后1个月针刺蝶腭神经节组复发天数[(4.12±2.15)d 比(23.53±4.63)d，t＝-8.879]明显少于常规针刺组(P＜0.01)。结论针刺蝶腭神经节治疗中重度持续性变应性鼻炎优于传统针刺方法。
目的：評價針刺蝶腭神經節治療中重度持續性變應性鼻炎的臨床療效。方法本研究為非隨機對照研究。將符閤納入標準的患者按就診順序以1∶1比例分為2組，每組25例。針刺蝶腭神經節組採用毫針刺激蝶腭神經節，1～2次/週；常規針刺組採用傳統針刺方法，以迎香、印堂、風池、風府、足三裏等為主穴，以上星、閤穀、禾髎、肺俞、脾俞、腎俞、三陰交等為配穴，每次取主穴、配穴各1～2穴，2次/週。2組均連續治療4週。採用鼻炎癥狀總分量錶(2004版)、鼻炎癥狀總分量錶(total nasal symptom score, TNSS)、鼻炎伴隨癥狀總分量錶(total non-nasal symptom score, TNNSS)評價癥狀改善情況；採用鼻結膜炎生活質量量錶(rhinoconjunctivitis quality of life questionnaire, RQLQ)評價生活質量；比較2組患者針刺起效時間、療效持續時間，以及治療後1箇月複髮天數。結果針刺蝶腭神經節組治療後鼻炎癥狀總分[(99.74±31.89)分比(196.83±31.22)，t＝-4.912]、TNSS[(165.18±51.06)分比(209.37±53.31)分，t＝-4.032]、TNNSS[(33.63±12.37)分比(71.82±19.21)，t＝-3.463]均明顯低于常規針刺組(P 均＜0.05)。與常規針刺組比較，針刺蝶腭神經節組針刺後癥狀改善起效時間[(13.85±4.21)min 比(45.63±7.87)min；t＝-1.763,P＝0.008]更短，而療效持續時間[(37.92±9.94)h 比(3.35±1.23)h；t＝7.637,P＜0.01]更長。針刺蝶腭神經節組治療後4週RQLQ評分[(8.48±3.71)分比(37.68±12.46)分，F＝-7.312]低于常規針刺組(P＜0.01)。治療後1箇月針刺蝶腭神經節組複髮天數[(4.12±2.15)d 比(23.53±4.63)d，t＝-8.879]明顯少于常規針刺組(P＜0.01)。結論針刺蝶腭神經節治療中重度持續性變應性鼻炎優于傳統針刺方法。
목적：평개침자접악신경절치료중중도지속성변응성비염적림상료효。방법본연구위비수궤대조연구。장부합납입표준적환자안취진순서이1∶1비례분위2조，매조25례。침자접악신경절조채용호침자격접악신경절，1～2차/주；상규침자조채용전통침자방법，이영향、인당、풍지、풍부、족삼리등위주혈，이상성、합곡、화료、폐유、비유、신유、삼음교등위배혈，매차취주혈、배혈각1～2혈，2차/주。2조균련속치료4주。채용비염증상총분량표(2004판)、비염증상총분량표(total nasal symptom score, TNSS)、비염반수증상총분량표(total non-nasal symptom score, TNNSS)평개증상개선정황；채용비결막염생활질량량표(rhinoconjunctivitis quality of life questionnaire, RQLQ)평개생활질량；비교2조환자침자기효시간、료효지속시간，이급치료후1개월복발천수。결과침자접악신경절조치료후비염증상총분[(99.74±31.89)분비(196.83±31.22)，t＝-4.912]、TNSS[(165.18±51.06)분비(209.37±53.31)분，t＝-4.032]、TNNSS[(33.63±12.37)분비(71.82±19.21)，t＝-3.463]균명현저우상규침자조(P 균＜0.05)。여상규침자조비교，침자접악신경절조침자후증상개선기효시간[(13.85±4.21)min 비(45.63±7.87)min；t＝-1.763,P＝0.008]경단，이료효지속시간[(37.92±9.94)h 비(3.35±1.23)h；t＝7.637,P＜0.01]경장。침자접악신경절조치료후4주RQLQ평분[(8.48±3.71)분비(37.68±12.46)분，F＝-7.312]저우상규침자조(P＜0.01)。치료후1개월침자접악신경절조복발천수[(4.12±2.15)d 비(23.53±4.63)d，t＝-8.879]명현소우상규침자조(P＜0.01)。결론침자접악신경절치료중중도지속성변응성비염우우전통침자방법。
ObjectiveTo evaluate the efficacy of sphenopalatine ganglion stimulation with acupuncture for moderate-to-severe perennial allergic rhinitis.MethodsA total of 50 patients were recruited into a sphenopalatine ganglion stimulation group and a routine acupuncture group according to order of presentation, with 25 in each group. The sphenopalatine ganglion stimulation group received sphenopalatine ganglion stimulation with filiform needle, 1-2 sessions/week for 4 weeks. The routine acupuncture group received traditional acupuncture, withyingxiang(LI 20),yintang(GV29),fengchi(GB20),fengfu(GB16),zusanli(ST36) as the maln points, andyingxiang(LI 20),yintang(GV29),fengchi(GB20),fengfu(GB16),zusanli(ST36) as the adjunct points, 1-2 points from both the maln and adjunct points in each session, 2 sessions/week for 4 weeks. The nasal symptom score (2004 version), the total nasal symptom score (TNSS) and the total non-nasal symptom score (TNNSS) were used to evaluate symptom improvement. The Rhinoconjunctivitis Quality of Life Questionnalre (RQLQ) was used to assess the patients’ quality of life. The time to symptom alleviation, duration of symptom alleviation in every session and the recurrence duration during 1 month after the treatment were compared between the two groups.Results After the treatment, the score of the nasal symptom score (99.74 ± 31.89vs.196.83 ± 31.22;t=-4.912,P=0.001), TNSS (33.63 ± 12.37vs.71.82 ± 19.21;t=-3.463,P=0.003), TNNSS (33.63 ± 12.37vs.71.82 ± 19.21,t=-3.463,P=0.003) in the sphenopalatine ganglion stimulation were significant lower than those in the routine acupuncture group. Compared with the routine acupuncture group, the time to symptom alleviation was significant shorter (13.85 ± 4.21 minvs.45.63 ± 7.87 min;t=-1.763,P=0.008), while the duration of symptom alleviation was significant longer (37.92 ± 9.94 hvs.3.35 ± 1.23 h;t=7.637,P<0.01) after each session in the sphenopalatine ganglion stimulation group. Four weeks after the treatment, RQLQ score in the sphenopalatine ganglion stimulation group was significant lower than that in the routine acupuncture group (8.48 ± 3.71vs.37.68 ± 12.46;F=-7.312,P<0.01). The recurrence duration during 1 month after the treatment in the sphenopalatine ganglion stimulation group was significant longer than that in the routine acupuncture group (4.12 ± 2.15 dvs.23.53 ± 4.63 d;t=-8.879,P=0.003).ConclusionSphenopalatine Ganglion stimulation is superior to routine acupuncture in treatment of patients with moderate-to-severe perennial allergic rhinitis.
